BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23783842)

  • 1. Ammonium chloride enhances cisplatin cytotoxicity through DNA double-strand breaks in human cervical cancer cells.
    Xu Y; Wang N; Ding Y; Wang C; Yu Y; Liu S; Wang X; Li Z
    Oncol Rep; 2013 Sep; 30(3):1195-200. PubMed ID: 23783842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction and repair of DNA double-strand breaks using constant-field gel electrophoresis and apoptosis as predictive markers for sensitivity of cancer cells to cisplatin.
    Saleh EM; El-Awady RA; Anis N; El-Sharkawy N
    Biomed Pharmacother; 2012 Oct; 66(7):554-62. PubMed ID: 22939736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZM447439, the Aurora kinase B inhibitor, suppresses the growth of cervical cancer SiHa cells and enhances the chemosensitivity to cisplatin.
    Zhang L; Zhang S
    J Obstet Gynaecol Res; 2011 Jun; 37(6):591-600. PubMed ID: 21159048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterotrimeric stimulatory GTP-binding proteins inhibit cisplatin-induced apoptosis by increasing X-linked inhibitor of apoptosis protein expression in cervical cancer cells.
    Cho EA; Oh JM; Kim SY; Kim Y; Juhnn YS
    Cancer Sci; 2011 Apr; 102(4):837-44. PubMed ID: 21255191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential effects of the proteasome inhibitor bortezomib and chemotherapeutic agents in uterine cervical cancer cell lines.
    Miyamoto Y; Nakagawa S; Wada-Hiraike O; Seiki T; Tanikawa M; Hiraike H; Sone K; Nagasaka K; Oda K; Kawana K; Nakagawa K; Fujii T; Yano T; Kozuma S; Taketani Y
    Oncol Rep; 2013 Jan; 29(1):51-7. PubMed ID: 23064281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin C in synergism with cisplatin induces cell death in cervical cancer cells through altered redox cycling and p53 upregulation.
    Leekha A; Gurjar BS; Tyagi A; Rizvi MA; Verma AK
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2503-2514. PubMed ID: 27613187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of caspase family protease, caspase-3 on cisplatin-induced apoptosis in cisplatin-resistant A431 cell line.
    Mese H; Sasaki A; Nakayama S; Alcalde RE; Matsumura T
    Cancer Chemother Pharmacol; 2000; 46(3):241-5. PubMed ID: 11021742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
    Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
    Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of an association between human papillomavirus and impaired chemotherapy-induced apoptosis in cervical cancer cells.
    Padilla LA; Leung BS; Carson LF
    Gynecol Oncol; 2002 Apr; 85(1):59-66. PubMed ID: 11925121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting the cytoplasmic location of HMGB1 reverses cisplatin resistance in human cervical cancer cells.
    Xia J; Yu X; Song X; Li G; Mao X; Zhang Y
    Mol Med Rep; 2017 Jan; 15(1):488-494. PubMed ID: 27959427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model.
    Kendrick JE; Straughn JM; Oliver PG; Wang W; Nan L; Grizzle WE; Stockard CR; Alvarez RD; Buchsbaum DJ
    Gynecol Oncol; 2008 Mar; 108(3):591-7. PubMed ID: 18177927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasome inhibitor lactacystin enhances cisplatin cytotoxicity by increasing endoplasmic reticulum stress-associated apoptosis in HeLa cells.
    Xu Y; Li D; Zeng L; Wang C; Zhang L; Wang Y; Yu Y; Liu S; Li Z
    Mol Med Rep; 2015 Jan; 11(1):189-95. PubMed ID: 25323748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer.
    Casagrande N; De Paoli M; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D
    Gynecol Oncol; 2013 Dec; 131(3):744-52. PubMed ID: 24029417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papilloma virus 16 E6 RNA interference enhances cisplatin and death receptor-mediated apoptosis in human cervical carcinoma cells.
    Tan S; Hougardy BM; Meersma GJ; Schaap B; de Vries EG; van der Zee AG; de Jong S
    Mol Pharmacol; 2012 May; 81(5):701-9. PubMed ID: 22328720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ADPR)polymerase inhibition and apoptosis induction in cDDP-treated human carcinoma cell lines.
    Gambi N; Tramontano F; Quesada P
    Biochem Pharmacol; 2008 Jun; 75(12):2356-63. PubMed ID: 18468580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taurine enhances anticancer activity of cisplatin in human cervical cancer cells.
    Kim T; Kim AK
    Adv Exp Med Biol; 2013; 776():189-98. PubMed ID: 23392883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
    Shehata M; Shehata M; Shehata F; Pater A
    Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of cisplatin cytotoxicity by 9-aminocamptothecin.
    Goldwasser F; Valenti M; Torres R; Kohn KW; Pommier Y
    Clin Cancer Res; 1996 Apr; 2(4):687-93. PubMed ID: 9816219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic anticancer activity of Thiazolo[5,4-b]quinoline derivative D3CLP in combination with cisplatin in human cervical cancer cells.
    González-Sánchez I; Lira-Rocha A; Navarrete A; Loza-Mejía MA; Coronel-Cruz C; Mendoza-Rodríguez CA; Cerbón MA
    Anticancer Res; 2012 Dec; 32(12):5159-65. PubMed ID: 23225412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.